Kirkegaard-Biosca, C.; del Barrio-Tofiño, E.; Villamarín, M.; Larrosa, N.; Campany, D.; González-López, J.J.; Ferrer, R.; Viñado, B.; Doménech, L.; Sellarès-Nadal, J.;
et al. Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874. Antibiotics 2025, 14, 4.
https://doi.org/10.3390/antibiotics14010004
AMA Style
Kirkegaard-Biosca C, del Barrio-Tofiño E, Villamarín M, Larrosa N, Campany D, González-López JJ, Ferrer R, Viñado B, Doménech L, Sellarès-Nadal J,
et al. Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874. Antibiotics. 2025; 14(1):4.
https://doi.org/10.3390/antibiotics14010004
Chicago/Turabian Style
Kirkegaard-Biosca, Cristina, Ester del Barrio-Tofiño, Miguel Villamarín, Nieves Larrosa, David Campany, Juan José González-López, Ricard Ferrer, Belén Viñado, Laura Doménech, Julia Sellarès-Nadal,
and et al. 2025. "Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874" Antibiotics 14, no. 1: 4.
https://doi.org/10.3390/antibiotics14010004
APA Style
Kirkegaard-Biosca, C., del Barrio-Tofiño, E., Villamarín, M., Larrosa, N., Campany, D., González-López, J. J., Ferrer, R., Viñado, B., Doménech, L., Sellarès-Nadal, J., Escolà-Vergé, L., Fernández-Hidalgo, N., & Los-Arcos, I.
(2025). Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874. Antibiotics, 14(1), 4.
https://doi.org/10.3390/antibiotics14010004
